March 18, 2016 — The global market for brachytherapy reached $705 million in 2015, according to a report from MEDraysintell. Of that total, the high-dose rate (HDR) and low-dose-rate (LDR) segments accounted for just over 60 percent, while the microspheres and electronic brachytherapy commanded the remaining 40 percent.
The global brachytherapy market in 2015, expressed in U.S. dollars, has been affected by exchange rate fluctuations of the major currencies against the U.S. dollar. The brachytherapy market size displayed an annual growth of 3 percent during the last two years to reach $705 million in 2015. Without this exchange rate influence, MEDraysintell estimates that the brachytherapy market would have reached about $800 million, thereby exhibiting an annual growth of more than 8 percent.
The brachytherapy market is expected to reach $2 billion in 2030, growing by 8 percent annually, mainly driven by the microspheres market as well as electronic brachytherapy, which is gaining significant interest worldwide as a user-friendly technology. The LDR brachytherapy seeds market is expected to grow substantially in new large markets such as China and India because of its reduced cost, together with a high therapeutic success rate.
The top ten companies control about 80 percent of the world brachytherapy market and more than 20 companies share the remaining 20 percent. Several new companies have penetrated the brachytherapy market in the last few years and a few others are expected to join the market in the coming years.
For more information: www.medraysintell.com
March 28, 2024 
